Terms: = Breast cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
107 results:
1. LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.
Liu Y; Tang R; Cao Y; Wu N; Qin Q; Chen Y; Wei X; Ren J; Sun Y; Zhou H; Zhou Y; Li P
J Nanobiotechnology; 2024 Apr; 22(1):209. PubMed ID: 38664830
[TBL] [Abstract] [Full Text] [Related]
2. Bacteria-driven nanosonosensitizer delivery system for enhanced breast cancer treatment through sonodynamic therapy-induced immunogenic cell death.
Du M; Wang T; Peng W; Feng R; Goh M; Chen Z
J Nanobiotechnology; 2024 Apr; 22(1):167. PubMed ID: 38610042
[TBL] [Abstract] [Full Text] [Related]
3. Zirconium-containing nanoscale coordination polymers for positron emission tomography and fluorescence-guided cargo delivery to triple-negative breast tumors.
Li YP; Pan ZW; Jiang YJ; Peng YY; Cai T; Hong H; Wang XF
Acta Biomater; 2024 Apr; 179():313-324. PubMed ID: 38490483
[TBL] [Abstract] [Full Text] [Related]
4. Application of fluorocarbon nanoparticles of
Zhi L; Cheng C; Jing L; Zhi-Ping P; Lu Y; Yan T; Zhi-Gang W; Guo-Bing Y
J Nanobiotechnology; 2024 Mar; 22(1):107. PubMed ID: 38475902
[TBL] [Abstract] [Full Text] [Related]
5. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract] [Full Text] [Related]
6. Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells.
Zhou Z; Fan H; Yu D; Shi F; Li Q; Zhang Z; Wang X; Zhang X; Dong C; Sun H; Mi W
Bioorg Med Chem; 2023 Dec; 96():117526. PubMed ID: 38008041
[TBL] [Abstract] [Full Text] [Related]
7. Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC; Pepa M; Zaffaroni M; Vincini MG; Luraschi R; Vigorito S; Morra A; Dicuonzo S; Mazzola GC; Gerardi MA; Zerella MA; Cante D; Petrucci E; Borzì G; Marrocco M; Chieregato M; Iadanza L; Lobefalo F; Valenti M; Cavallo A; Russo S; Guernieri M; Malatesta T; Meaglia I; Liotta M; Palumbo I; Marcantonini M; Mezzenga E; Falivene S; Arrichiello C; Barbero MP; Ivaldi GB; Catalano G; Vidali C; Giannitto C; Ciabattoni A; Meattini I; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA
Tumori; 2023 Dec; 109(6):570-575. PubMed ID: 37688419
[TBL] [Abstract] [Full Text] [Related]
8. Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative breast cancer by Activating the NF-κB Pathway.
Kuang W; Gu Q; Zhou Y; Xiao X; He D; Deng Q
Cell Biochem Biophys; 2023 Dec; 81(4):727-735. PubMed ID: 37658975
[TBL] [Abstract] [Full Text] [Related]
9. Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Meric-Bernstam F; Calvo E; Lee KS; Moreno V; Park YH; Rha SY; Chalasani P; Zhong W; Zhou L; Pirie-Shepherd S; Leung ACF; Curigliano G
Mol Cancer Ther; 2023 Oct; 22(10):1191-1203. PubMed ID: 37420274
[TBL] [Abstract] [Full Text] [Related]
10. [Questionnaire Survey of treatment Strategies for Gastric cancer with Peritoneal Dissemination in Yamaguchi Prefecture].
Nakashima C; Iida M; Takeda S; Harada E; Miyazaki K; Kondo J; Kawaoka T; Oka I; Watanabe M; Takahashi T; Ioka T; Hamano K; Nagano H
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1616-1618. PubMed ID: 36733153
[TBL] [Abstract] [Full Text] [Related]
11. Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
Kim H; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH
PLoS One; 2022; 17(3):e0265533. PubMed ID: 35294484
[TBL] [Abstract] [Full Text] [Related]
12. DNA binding and cleavage, BRCA1 gene interaction, antiglycation and anticancer studies of transition metal complexes of sulfonamides.
Akhtar A; Danish M; Asif A; Arshad MN; Asiri AM
Mol Divers; 2022 Dec; 26(6):3093-3113. PubMed ID: 35182295
[TBL] [Abstract] [Full Text] [Related]
13. Can assessment of disease burden and quality of life based on mobility level in patients with end-stage cancer provide an insight into unmet needs? An exploratory cross-sectional study.
Bahar-Ozdemir Y; Kaya S; Babacan NA; Al T; Albayrak E; Coskun N; Akyuz G
Physiother Theory Pract; 2023 Jun; 39(6):1141-1151. PubMed ID: 35100940
[TBL] [Abstract] [Full Text] [Related]
14. The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC; Pepa M; Luraschi R; Vigorito S; Dicuonzo S; Isaksson LJ; La Porta MR; Marino L; Ippolito E; Huscher A; Argenone A; De Rose F; Cucciarelli F; De Santis MC; Rossi F; Prisco A; Guarnaccia R; Tabarelli de Fatis P; Palumbo I; Colangione SP; Mormile M; Ravo V; Fozza A; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA;
Radiother Oncol; 2022 Mar; 168():113-120. PubMed ID: 35033602
[TBL] [Abstract] [Full Text] [Related]
15. Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant breast cancer treatment: A Feasibility Study.
Faravel K; Huteau ME; Jarlier M; de Forges H; Meignant L; Senesse P; Norton J; Jacot W; Stoebner A
Integr Cancer Ther; 2021; 20():15347354211063791. PubMed ID: 34939444
[TBL] [Abstract] [Full Text] [Related]
16. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer.
Bassez A; Vos H; Van Dyck L; Floris G; Arijs I; Desmedt C; Boeckx B; Vanden Bempt M; Nevelsteen I; Lambein K; Punie K; Neven P; Garg AD; Wildiers H; Qian J; Smeets A; Lambrechts D
Nat Med; 2021 May; 27(5):820-832. PubMed ID: 33958794
[TBL] [Abstract] [Full Text] [Related]
17. Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for breast cancer Theranostics.
Li L; Fu J; Wang X; Chen Q; Zhang W; Cao Y; Ran H
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3605-3621. PubMed ID: 33449625
[TBL] [Abstract] [Full Text] [Related]
18. Diet Quality Is Associated with Serum Antioxidant Capacity in Women with breast cancer: A Cross Sectional Study.
Reitz LK; Baptista SL; Santos EDS; Hinnig PF; Rockenbach G; Vieira FGK; de Assis MAA; da Silva EL; Boaventura BCB; Pietro PFD
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396963
[TBL] [Abstract] [Full Text] [Related]
19. Iron(II) phthalocyanine Loaded and AS1411 Aptamer Targeting Nanoparticles: A Nanocomplex for Dual Modal Imaging and Photothermal Therapy of breast cancer.
He Y; Wang M; Fu M; Yuan X; Luo Y; Qiao B; Cao J; Wang Z; Hao L; Yuan G
Int J Nanomedicine; 2020; 15():5927-5949. PubMed ID: 32848397
[TBL] [Abstract] [Full Text] [Related]
20. [breast cancer management before 40 years: what change in one decade? A retrospective study at the "Institut de cancérologie de Lorraine": 2002-2012].
Soussoko M; Salleron J; Desandes E; Lesur A
Bull Cancer; 2019 Dec; 106(12S1):S60-S74. PubMed ID: 32008740
[TBL] [Abstract] [Full Text] [Related]
[Next]
